These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16889199)

  • 41. Thromboembolism in women.
    Martinelli I
    Semin Thromb Hemost; 2006 Oct; 32(7):709-15. PubMed ID: 17024598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inherited thrombophilia and pregnancy complications revisited.
    Rodger MA; Paidas M; McLintock C; Middeldorp S; Kahn S; Martinelli I; Hague W; Rosene Montella K; Greer I
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):320-4. PubMed ID: 18669729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epidemiology and maternal thrombosis].
    Bosson JL
    Ann Med Interne (Paris); 2003; 154(5-6):283-5. PubMed ID: 15027579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia.
    Weintraub AY; Sheiner E
    Arch Gynecol Obstet; 2007 Dec; 276(6):567-71. PubMed ID: 17828548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects.
    Folkeringa N; Brouwer JL; Korteweg FJ; Veeger NJ; Erwich JJ; van der Meer J
    Br J Haematol; 2007 Jul; 138(1):110-6. PubMed ID: 17555454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Which patients are at risk of pregnancy vascular diseases as a function of their biological status?].
    Imbert B
    Ann Med Interne (Paris); 2003; 154(5-6):414-21. PubMed ID: 15027599
    [No Abstract]   [Full Text] [Related]  

  • 47. Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5,000 patients.
    Kocher O; Cirovic C; Malynn E; Rowland CM; Bare LA; Young BA; Henslee JG; Laffler TG; Huff JB; Kruskall MS; Wong G; Bauer KA
    Am J Clin Pathol; 2007 Jan; 127(1):68-75. PubMed ID: 17145624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes.
    Duhl AJ; Paidas MJ; Ural SH; Branch W; Casele H; Cox-Gill J; Hamersley SL; Hyers TM; Katz V; Kuhlmann R; Nutescu EA; Thorp JA; Zehnder JL;
    Am J Obstet Gynecol; 2007 Nov; 197(5):457.e1-21. PubMed ID: 17980177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pregnancy failure and heritable thrombophilia.
    Middeldorp S
    Semin Hematol; 2007 Apr; 44(2):93-7. PubMed ID: 17433901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombophilia and adverse maternal-perinatal outcome.
    Stella CL; Sibai BM
    Clin Obstet Gynecol; 2006 Dec; 49(4):850-60. PubMed ID: 17082680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for venous thromboembolism in pregnancy.
    McColl MD; Walker ID; Greer IA
    Curr Opin Pulm Med; 1999 Jul; 5(4):227-32. PubMed ID: 10407692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Thrombophilia and pregnancy: who should be tested? Which tests should be performed? The biologist point of view].
    Conard J
    Ann Med Interne (Paris); 2003; 154(5-6):340-4. PubMed ID: 15027588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
    Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
    J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein S and congenital protein S deficiency: the most frequent congenital thrombophilia in Japanese.
    Adachi T
    Curr Drug Targets; 2005 Aug; 6(5):585-92. PubMed ID: 16026279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
    Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
    Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants.
    Grandone E; De Stefano V; Rossi E; Cappucci F; Colaizzo D; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):226-30. PubMed ID: 18388503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss, a retrospective study.
    Folkeringa N; Korteweg FJ; Veeger NJ; Middeldorp S; Hamulyak K; Prins MH; Erwich JJ; Büller HR; van der Meer J
    Thromb Res; 2009; 123(3):511-4. PubMed ID: 18455758
    [No Abstract]   [Full Text] [Related]  

  • 58. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
    White RH; Chan WS; Zhou H; Ginsberg JS
    Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prophylaxis and treatment of venous thromboembolism in individuals with inherited thrombophilia.
    De Stefano V; Rossi E; Za T; Leone G
    Semin Thromb Hemost; 2006 Nov; 32(8):767-80. PubMed ID: 17171589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inherited thrombophilia markers in Malaysian women with recurrent fetal loss.
    Ayadurai T; Ayob Y; Muniandy S; Omar SZ
    Thromb Haemost; 2007 Nov; 98(5):1152-4. PubMed ID: 18000628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.